By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
AdkhabarAdkhabarAdkhabar
Notification Show More
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
AdkhabarAdkhabar
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Search
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Follow US
Biomea Fusion Presents New Clinical and Translational Data for Icovamenib at the American Diabetes Association (ADA) 86th Scientific Sessions and Announces Expansion of Ongoing Phase I BMF-650 Study
Health

Biomea Fusion Presents New Clinical and Translational Data for Icovamenib at the American Diabetes Association (ADA) 86th Scientific Sessions and Announces Expansion of Ongoing Phase I BMF-650 Study

•Translational data presented at ADA demonstrate icovamenib’s potential to promote muscle preservation…

GlobeNews Wire
GlobeNews Wire
06/06/2026
Hengrui Pharma and Kailera Therapeutics Present Ribupatide Clinical Data at ADA 2026
Health

Hengrui Pharma and Kailera Therapeutics Present Ribupatide Clinical Data at ADA 2026

Presentations will feature clinical results for ribupatide, a GLP-1/GIP receptor dual agonist…

GlobeNews Wire
GlobeNews Wire
06/06/2026
Oban BioPharma Announces Presentation of Late-Breaking Abstract at ADA 2026 Highlighting OBT-676: A First-in-Class Small Molecule Combining Dual Amylin and Calcitonin Receptor Full Agonism (DACRA) with GLP-1, GIP and Glucagon (Triple-G) Receptor Partial A
Health

Oban BioPharma Announces Presentation of Late-Breaking Abstract at ADA 2026 Highlighting OBT-676: A First-in-Class Small Molecule Combining Dual Amylin and Calcitonin Receptor Full Agonism (DACRA) with GLP-1, GIP and Glucagon (Triple-G) Receptor Partial A

June 05, 2026 19:30 ET  | Source: Oban BioPharma, Inc. STAMFORD, Conn.,…

GlobeNews Wire
GlobeNews Wire
06/06/2026
Cullinan Therapeutics Presents Initial Clinical Data for CLN-978, a CD19xCD3 T Cell Engager, at the EULAR 2026 Congress
Health

Cullinan Therapeutics Presents Initial Clinical Data for CLN-978, a CD19xCD3 T Cell Engager, at the EULAR 2026 Congress

Clinical benefit, including remissions, demonstrated in both systemic lupus erythematosus (SLE) and…

GlobeNews Wire
GlobeNews Wire
06/06/2026
Bluejay Diagnostics Announces Closing of Up to .7 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Health

Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules

June 05, 2026 20:13 ET  | Source: Bluejay Diagnostics, Inc. $8.5 million…

GlobeNews Wire
GlobeNews Wire
06/06/2026
Data at ADA 2026 Highlights Key Findings from Clinical and RealWorld Studies of MannKinds Afrezza (Inhaled Insulin) Across Pediatric Care, Pregnancy, and Use with Automated Insulin Delivery (AID) Systems
Health

Data at ADA 2026 Highlights Key Findings from Clinical and RealWorld Studies of MannKinds Afrezza (Inhaled Insulin) Across Pediatric Care, Pregnancy, and Use with Automated Insulin Delivery (AID) Systems

Builds on recent FDA approval (May 29, 2026) of Afrezza for use…

GlobeNews Wire
GlobeNews Wire
06/06/2026
Chandigarh University holds 8th CU Online Annual Convocation; 363 Students Degrees Awarded
News

Chandigarh University holds 8th CU Online Annual Convocation; 363 Students Degrees Awarded

Chandigarh University Sings MoU with Global Consulting Giant PwC to Offer Online…

06/06/2026
SHARE3DCAM Launches AI Engine Algorithm Upgrade in SHARE PointClouds Studio V2.5.0, Advancing the Complete Scan-to-Deliverable Workflow for AEC and Renovation Professionals
Technology

SHARE3DCAM Launches AI Engine Algorithm Upgrade in SHARE PointClouds Studio V2.5.0, Advancing the Complete Scan-to-Deliverable Workflow for AEC and Renovation Professionals

Shenzhen, June 05, 2026 (GLOBE NEWSWIRE) -- SHARE3DCAM, a developer of professional…

GlobeNews Wire
GlobeNews Wire
06/06/2026
All-Round for Work & Play: KTC Dual-Mode Monitor H27P6 Adapts to Full-Scenario Needs
Technology

All-Round for Work & Play: KTC Dual-Mode Monitor H27P6 Adapts to Full-Scenario Needs

Houston, Texas, USA, June 05, 2026 (GLOBE NEWSWIRE) -- I. Hybrid Work…

GlobeNews Wire
GlobeNews Wire
06/06/2026
NatureU Now Has Three Clinical Studies Publicly Registered on ClinicalTrials.gov as 56-Day PQQ Skin-Aging Study (NCT07571629) Joins Two Previously Published Peer-Reviewed Trials
Technology

NatureU Now Has Three Clinical Studies Publicly Registered on ClinicalTrials.gov as 56-Day PQQ Skin-Aging Study (NCT07571629) Joins Two Previously Published Peer-Reviewed Trials

Kwun Tong, Kowloon, HK, June 05, 2026 (GLOBE NEWSWIRE) -- The newly…

GlobeNews Wire
GlobeNews Wire
06/06/2026
1 2 … 37 38 39 40 41 … 1,101 1,102
- Advertisement -

Follow US

Find US on Social Medias
FacebookLike
XFollow
YoutubeSubscribe

Weekly Newsletter

Subscribe to our newsletter to get our newest articles instantly!
Popular News
Tecan to host Analyst and Media Conference with Capital Markets Update on March 16, 2026
Health

Tecan to host Analyst and Media Conference with Capital Markets Update on March 16, 2026

GlobeNews Wire
GlobeNews Wire
10/02/2026
NYSE Content Update: Artemis II Crew to Take Part in ‘Bell Moment’ at NYSE
Benchling Partners with Anthropic to Build a Bridge Between Science and AI
Wynn Honors the Top-Tier Wines of China at the 2026 Wynn Signature Chinese Wine Awards Ceremony
Nexteer Recognized with 2025 AutoTech Breakthrough Award For “Automotive Software Solution of the Year”
- Advertisement -
- Advertisement -
- Advertisement -

Categories

  • Automobile
  • Entertainment
  • E-Sports
  • Food
  • Health
  • Technology
  • LifeStyle
  • Travel

About Us

Through our news networks, we raise millions of users' awareness. We are among the world's most reputable news networks.
Quick Link
Top Categories
  • Entertainment

Subscribe US

Subscribe to our newsletter to get our newest articles instantly!

AdkhabarAdkhabar
Copyright © 2021 - 2025 AdKhabar. All Rights Reserved. POWERED BY Life Care News.
Join Us!
Subscribe to our newsletter and never miss our latest news, podcasts etc..
Zero spam, Unsubscribe at any time.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?